Global and United States Molecular Diagnostics in Infectious Disease Testing Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.4 Microarrays
1.2.5 Next-Generation Sequencing (NGS)
1.2.6 Hybridization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2015-2026)
2.2 Global Molecular Diagnostics in Infectious Disease Testing Growth Trends by Regions
2.2.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Share by Regions (2015-2020)
2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Market Size
3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2015-2020)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2015-2020)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2019
3.5 Key Players Molecular Diagnostics in Infectious Disease Testing Area Served
3.6 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type (2015-2026)
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2015-2020)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2021-2026)
5 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application (2015-2026)
5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2015-2020)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2026)
6.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
6.4 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2026)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
7.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2026)
8.2 China Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
8.3 China Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
8.4 China Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2026)
9.2 Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
9.3 Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
9.4 Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size (2015-2026)
10.2 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.2.5 BD Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
11.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.3.5 BioMerieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
11.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.5.5 Roche Recent Development
11.6 Siemens
11.6.1 Siemens Company Details
11.6.2 Siemens Business Overview
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
11.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.6.5 Siemens Recent Development
11.7 Veridex
11.7.1 Veridex Company Details
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Details
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
11.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
11.10.5 Qiagen Recent Development
11.11 Genomix Biotech
10.11.1 Genomix Biotech Company Details
10.11.2 Genomix Biotech Business Overview
10.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
10.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
10.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
10.12.1 BioTheranostics Company Details
10.12.2 BioTheranostics Business Overview
10.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
10.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
10.12.5 BioTheranostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Polymerase Chain Reaction (PCR)
Table 4. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 5. Key Players of Microarrays
Table 6. Key Players of Next-Generation Sequencing (NGS)
Table 7. Key Players of Hybridization
Table 8. Key Players of Others
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2015-2020)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2021-2026)
Table 15. Molecular Diagnostics in Infectious Disease Testing Market Market Trends
Table 16. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 17. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 18. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 19. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2015-2020) (US$ Million)
Table 20. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2015-2020)
Table 21. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2019)
Table 22. Global Molecular Diagnostics in Infectious Disease Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Type (2015-2020)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Application (2015-2020)
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size Share by Application (2021-2026)
Table 32. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 33. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 34. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 35. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 36. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 37. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2015-2020)
Table 38. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 39. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 40. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 41. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 42. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 43. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2015-2020)
Table 44. China Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 45. China Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 46. China Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 47. China Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 48. China Molecular Diagnostics in Infectious Disease Testing Market Size by Region (US$ Million) (2015-2020)
Table 49. China Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2015-2020)
Table 50. Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 51. Japan Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 52. Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 53. Japan Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 54. Japan Molecular Diagnostics in Infectious Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 55. Japan Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2015-2020)
Table 56. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 57. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Share by Type (2015-2020)
Table 58. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 59. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Share by Application (2015-2020)
Table 60. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 61. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2015-2020)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Product
Table 65. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 66. Abbott Recent Development
Table 67. BD Company Details
Table 68. BD Business Overview
Table 69. BD Product
Table 70. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 71. BD Recent Development
Table 72. BioMerieux Company Details
Table 73. BioMerieux Business Overview
Table 74. BioMerieux Product
Table 75. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 76. BioMerieux Recent Development
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Product
Table 80. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 81. Thermo Fisher Scientific Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 86. Roche Recent Development
Table 87. Siemens Company Details
Table 88. Siemens Business Overview
Table 89. Siemens Product
Table 90. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 91. Siemens Recent Development
Table 92. Veridex Company Details
Table 93. Veridex Business Overview
Table 94. Veridex Product
Table 95. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 96. Veridex Recent Development
Table 97. Luminex Business Overview
Table 98. Luminex Product
Table 99. Luminex Company Details
Table 100. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 101. Luminex Recent Development
Table 102. GenMark Diagnostics Company Details
Table 103. GenMark Diagnostics Business Overview
Table 104. GenMark Diagnostics Product
Table 105. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 106. GenMark Diagnostics Recent Development
Table 107. Qiagen Company Details
Table 108. Qiagen Business Overview
Table 109. Qiagen Product
Table 110. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 111. Qiagen Recent Development
Table 112. Genomix Biotech Company Details
Table 113. Genomix Biotech Business Overview
Table 114. Genomix Biotech Product
Table 115. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 116. Genomix Biotech Recent Development
Table 117. BioTheranostics Company Details
Table 118. BioTheranostics Business Overview
Table 119. BioTheranostics Product
Table 120. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020) (US$ Million)
Table 121. BioTheranostics Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 4. Microarrays Features
Figure 5. Next-Generation Sequencing (NGS) Features
Figure 6. Hybridization Features
Figure 7. Others Features
Figure 8. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions: 2020 VS 2026
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Regions (2021-2026)
Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2019
Figure 19. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2019
Figure 21. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. United States Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Canada Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Germany Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. France Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Italy Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Russia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Nordic Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Australia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Rest of Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. UAE Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 49. BD Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 50. BioMerieux Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 52. Roche Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 53. Siemens Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 54. Veridex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 55. Luminex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 56. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 57. Qiagen Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 58. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 59. BioTheranostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed